Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Eugene J. Barrett(University of Virginia), Carolina Casellini(Eastern Virginia Medical School), Mogher Khamaisi(Joslin Diabetes Center), Zhenqi Liu(University of Virginia Health System), Donald W. Bowden(Wake Forest University), Ronald Klein(University of Wisconsin–Madison), Timothy M. Hughes(University of North Carolina at Chapel Hill), Barry I. Freedman(Wake Forest University), George L. King(Joslin Diabetes Center), Aaron I. Vinik(Eastern Virginia Medical School), Suzanne Craft(Wake Forest University)
Cited by 513
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k